Insights for Care: The Healthcare Utilisation and Cost Impact of Managing Type 2 Diabetes-Associated Microvascular Complications

[1] Holman N(2015)Current prevalence of type 1 and type 2 diabetes in adults and children in the UK Diabet Med 32 1119-1120

[2] Young B(2000)Socio-economic status, obesity and prevalence of type 1 and type 2 diabetes mellitus Diabet Med 17 478-480

[3] Gadsby R(2014)Chronic disease burden associated with overweight and obesity in Ireland: the effects of a small BMI reduction at population level BMC Public Health 14 143-578

[4] Evans JM(2014)Assessment of unmet clinical need in type 2 diabetic patients on conventional therapy in the UK Diabetes Ther 5 567-862

[5] Newton RW(2012)Estimating the current and future costs of type 1 and type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs Diabet Med 29 855-82

[6] Ruta DA(2016)Insights for care: using real-world data to quantify diabetes treatment patterns and outcomes in an urban health economy Value Health 19 A83-2608

[7] MacDonald TM(2008)Microvascular and macrovascular complications of diabetes Clin Diabetes 26 77-713

[8] Morris AD(2003)Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice Diabetes Care 26 2604-176

[9] Kearns K(2016)Insights for Care: building a pseudonymised, linked, crosssetting real-world evidence research alliance in Birmingham Value Health 19 A211-571

[10] Dee A(1998)Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group BMJ 317 703-230

[1] Holman N(2015)Current prevalence of type 1 and type 2 diabetes in adults and children in the UK Diabet Med 32 1119-1120

[2] Young B(2000)Socio-economic status, obesity and prevalence of type 1 and type 2 diabetes mellitus Diabet Med 17 478-480

[3] Gadsby R(2014)Chronic disease burden associated with overweight and obesity in Ireland: the effects of a small BMI reduction at population level BMC Public Health 14 143-578

[4] Evans JM(2014)Assessment of unmet clinical need in type 2 diabetic patients on conventional therapy in the UK Diabetes Ther 5 567-862

[5] Newton RW(2012)Estimating the current and future costs of type 1 and type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs Diabet Med 29 855-82

[6] Ruta DA(2016)Insights for care: using real-world data to quantify diabetes treatment patterns and outcomes in an urban health economy Value Health 19 A83-2608

[7] MacDonald TM(2008)Microvascular and macrovascular complications of diabetes Clin Diabetes 26 77-713

[8] Morris AD(2003)Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice Diabetes Care 26 2604-176

[9] Kearns K(2016)Insights for Care: building a pseudonymised, linked, crosssetting real-world evidence research alliance in Birmingham Value Health 19 A211-571

[10] Dee A(1998)Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group BMJ 317 703-230